CherylSwanson

Cheryl Swanson

CherylSwanson’s Activity

Tue Sep 13

NL

Article

CherylSwanson published an article 6:05 PM

Move Over, Intuitive Surgical, Here's How Johnson & Johnson and Google Plan to Build a Better Robot

With J&J and Google planning to build a robotic assistant the size of Star Wars' C-3PO -- and almost as smart as WALL-E -- Intuitive Surgical may need to step up its game.

Sat Sep 10

NL

Article

CherylSwanson published an article 8:11 PM

Why Allergan Should Start Paying a Dividend

A dividend would make this stock appealing to long-term investors, and with its newfound cash bounty, Allergan can certainly afford it.

Thu Sep 8

NL

Article

CherylSwanson published an article 3:31 AM

You'll Never Guess Which Pharma Could Knock Gilead Sciences Off Its HIV Throne

This Big Pharma is advancing a revolutionary dual HIV therapy that could give Gilead a run for its money and change the standard of care for HIV.

Sun Sep 4

NL

Article

CherylSwanson published an article 11:33 PM

Why Pfizer's Stock Is a Big Gamble Right Now

While Pfizer’s recent M&A deals are focused on rebuilding, three near-term risks could bring the walls crumbling down.

NL

Article

CherylSwanson published an article 5:19 AM

3 Great Dividend Stocks in the Bargain Bin for Retirees

Short-term disappointments have tossed these three stand-out stocks on the discount rack.

Thu Sep 1

NL

Article

CherylSwanson published an article 10:51 PM

How the Tides Are Turning in Alzheimer's Research

By aiming their drug candidates at earlier stages of the disease, Biogen and Lilly may be closing in on an effective treatment.

Wed Aug 31

NL

Article

CherylSwanson published an article 7:03 PM

The Only Thing More Extraordinary Than GlaxoSmithKline's Growth Strategy Is That It's Working

In an industry under fire for sky-high drug pricing, GlaxoSmithKline is blazing a new trail.

Mon Aug 29

NL

Article

CherylSwanson published an article 11:23 PM

How Google Plans to Reinvent Healthcare

The tech titan wants to change the future of healthcare. But first, it needs to come up with a useful product.

Fri Aug 26

NL

Article

CherylSwanson published an article 5:40 PM

Clovis Oncology Speeds Toward Possible Launch in Ovarian Cancer, but Red Flags Remain

A recently granted priority review has this stock jumping, but watch out. The company's chequered history merits caution.

Tue Aug 23

NL

Article

CherylSwanson published an article 6:55 PM

Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could B

Pfizer's knockout $14 billion acquisition of Medivation shocked even the most optimistic biotech bulls. But here’s why the giant pharma jumped into this deal with both feet.

NL

Article

CherylSwanson published an article 12:46 AM

Could Toxicity Issues Topple CAR-T Cancer Therapies?

After deadly clinical trials, should investors fear safety issues might further delay or even topple CAR-T therapies and stocks?

Sun Aug 21

NL

Article

CherylSwanson published an article 11:31 PM

Thermo Fisher to Buy Illumina? Not So Fast

The rumors of a $30 billion megamerger likely don’t hold water, but they could still point to some upside in gene-sequencing stocks.

Fri Aug 19

NL

Article

CherylSwanson published an article 1:02 AM

Allergan Makes an Eye-Opening Acquisition

Allergan is back on the hunt for deals -- but not the ones you might expect.

Thu Aug 18

NL

Article

CherylSwanson published an article 2:43 AM

Why I Hate Johnson & Johnson Right Now (But I'll Never Sell)

With a key patent for Remicade just invalidated and a copycat drug looming, J&J may be due for a haircut.

Tue Aug 16

NL

Article

CherylSwanson published an article 5:34 PM

3 Reasons Medivation Is the Juiciest Target in Biotech

Seemingly half the world's pharma companies are chasing this relatively unknown biotech. Here's why.

Sun Aug 14

NL

Article

CherylSwanson published an article 8:42 PM

3 Dividend Stocks to Make Your Retirement Sweeter

These companies should keep raising their dividends while you find fun things to do when you retire.

Sat Aug 13

NL

Article

CherylSwanson published an article 4:43 PM

Why Pfizer's Acquisition of Anacor Is a Great Fit

This boron-based biotech could open some exciting drug-development pathways for Pfizer.

Fri Aug 12

NL

Article

CherylSwanson published an article 9:12 PM

Pfizer's Bold Bid to Conquer Cancer

Pfizer is hustling to become an oncology powerhouse, which could pay off big time for investors and patients.

Fri Jul 22

NL

Article

CherylSwanson published an article 3:38 AM

The Drug-Price War Just Took a Big New Twist

As states and insurers are forced to unlock access to pricey hep-C wonder drugs, the wind may be shifting in favor of biotech and pharma investors.

Sat Jul 16

NL

Article

CherylSwanson published an article 1:20 AM

3 Biotech Stocks That Could Soar Over the Next 12 Months

Biotech is down, but not out. In fact, our contributors see these three stocks as great bets for an explosive recovery.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 70759
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 3
Total Picks 3
Best Pick EW (+22.27)
Worst Pick GILD (-50.64)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to CherylSwanson’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show CherylSwanson’s 10 Latest Posts